Phase I trial of a patch-based influenza vaccine.
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2012
At a glance
- Drugs Influenza virus vaccine (Primary) ; Heat-labile enterotoxin E coli
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Intercell USA
- 15 Nov 2012 Status changed from active, no longer recruiting to completed.
- 25 May 2007 Status change from inititated to in progress; interim results reported.
- 14 Sep 2006 New trial record.